Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1131 GRWD5769: A first-in-class inhibitor of ERAP1, generating novel cancer antigens to drive de novo anti-tumor T cell responses
Compose a Response to This Article
Other responses
No responses have been published for this article.